Endo To Boost Sales Force Following Frova In-Licensing Deal With Vernalis

The company will add about 70-80 reps to its existing sales force base of 230; detailing for the triptan will target specialty care physicians. Endo will make a $40 mil. milestone payment to Vernalis upon FDA approval for a menstrually associated migraine indication.